Ibelis Montesino - May 1, 2025 Form 3 Insider Report for HERBALIFE LTD. (HLF)

Role
MD, North America
Signature
/s/ Alaaeddine Sahibi, as Attorney-In-Fact for Ibelis Montesino
Stock symbol
HLF
Transactions as of
May 1, 2025
Transactions value $
$0
Form type
3
Date filed
5/12/2025, 07:37 PM
Previous filing
May 7, 2024
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Montesino Ibelis MD, North America 800 W. OLYMPIC BLVD., SUITE 406, LOS ANGELES /s/ Alaaeddine Sahibi, as Attorney-In-Fact for Ibelis Montesino 2025-05-12 0001513887

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding HLF Common Stock 33.5K May 1, 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding HLF Stock Appreciation Rights May 1, 2025 Common Stock 80K $13.60 Direct F2
holding HLF Stock Appreciation Rights May 1, 2025 Common Stock 30.1K $18.61 Direct F3
holding HLF Stock Appreciation Rights May 1, 2025 Common Stock 152K $9.58 Direct F4
holding HLF Stock Appreciation Rights May 1, 2025 Common Stock 55.3K $8.31 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Balance includes 33,058 unvested restricted stock units ("RSUs") previously granted to the Reporting Person, of which: 14,236 were granted on November 2, 2022, of which 40% has vested, and 60% will vest on November 2, 2025; 11,948 were granted on May 4, 2023, of which 2/3 have vested, and 1/3 will vest on May 4, 2026; 4,701 were granted on August 4, 2023, of which 1/3 has vested, 1/3 will vest on August 3, 2025, and 1/3 will vest on August 3, 2026; 26,096 were granted on May 3, 2024, of which 1/3 has vested, 1/3 will vest on May 3, 2026, and 1/3 will vest on May 3, 2027. All RSU vestings are subject to continued service through each applicable date.
F2 On May 4, 2023, the reporting person was granted 80,049 stock appreciation rights ("SARs") that vests in 1/3 increments on the annual anniversary of the date of grant.
F3 On August 4, 2023, the reporting person was granted 30,068 SARs which vests in 1/3 increments on the annual anniversary of the date of grant.
F4 On May 3, 2024, the reporting person was granted 151,821 SARs which vests in 1/3 increments on the annual anniversary of the date of grant.
F5 On February 21, 2025, the reporting person was granted 55,309 SARs which vests in 1/3 increments on the annual anniversary of the date of grant.